Aliases: CGI-92.
COQ4 (coenzyme Q4) is named by 2 disorder entries.
ai-gene-review gives COQ4's core molecular functions as 4-hydroxy-3-methoxy-5-polyprenylbenzoate decarboxylase activity; and zinc ion binding, acting in ubiquinone biosynthetic process. COQ4 is therefore both a catalytic enzyme, the zinc-dependent C1 decarboxylase of the coenzyme Q head group, and a subunit of the CoQ biosynthetic complex.
Both entries type COQ4 as causative: COQ4-Related Neonatal Encephalomyopathy; and Primary Coenzyme Q10 Deficiency. Both record the variants as germline (COQ4-Related Neonatal Encephalomyopathy; and Primary Coenzyme Q10 Deficiency).
In Primary Coenzyme Q10 Deficiency the gene sits on Defective Benzoquinone Head-Group Modification, the node for the ring-modifying enzymes, and on the shared node Defective CoQ10 Biosynthesis. The gene-specific entry places it on COQ4 Loss of Function and CoQ Synthome Destabilization, whose name reflects the older view of COQ4 as a structural organizer of the complex rather than its catalytic decarboxylase role.
The KB mechanism nodes and ai-gene-review share ubiquinone biosynthetic process as a GO process by exact identifier.
ClinGen classifies COQ4 for 1 disease with no matching dismech entry: mitochondrial disease. That lumped disease is broader than either COQ4 entry, so its tier is not copied onto them.
Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.
ai-gene-review has this gene at status INITIALIZED; the description is shown only once the review is complete. Read the draft upstream.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| COQ4-Related Neonatal Encephalomyopathy | causative germline |
mechanism: COQ4 Loss of Function and CoQ Synthome Destabilization
|
| Primary Coenzyme Q10 Deficiency | causative germline |
mechanism: Defective Benzoquinone Head-Group Modification; Defective CoQ10 Biosynthesis
subtype: COQ4
scoped to subtype: COQ4
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| mitochondrial disease MONDO:0044970 | AR | Definitive 2023-01-30 |
no dismech entry |
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.